Skip to main content
OpenTrials

Clinical trial condition

Solid Tumor, Adult

Explore clinical trials studying Solid Tumor, Adult. Study availability and eligibility vary by location and protocol.

198 public trials 84 recruiting studies
Refine in advanced search Browse all conditions

Solid Tumor, Adult trial results

Active, Not Recruiting

Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors

NCT04041310

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope Comprehensive Cancer Center Irvine, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Newport Beach, California, United States
View all 46 locations
View Trial Details
Active, Not Recruiting

Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors

NCT05651022

Conditions
Adenocarcinoma, Bronchial Neoplasms, CRC (Colorectal Cancer), +31 more
Locations
  • University of Southern California- Norris Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • The Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Active, Not Recruiting

First-in-Human Study of the GDF-15 Neutralizing Antibody Visugromab (CTL-002) in Patients With Advanced Cancer (GDFATHER)

NCT04725474

Conditions
Solid Tumor, Adult
Locations
  • Universitätsklinikum Essen, Westdeutsches Tumorzentrum, Innere Klinik und Poliklinik Essen, Germany
  • Universitätsklinikum Frankfurt, Medizinische Klinik I Frankfurt am Main, Germany
  • Universitätsklinikum Würzburg, Comprehensive Cancer Center Würzburg, Germany
  • Next Oncology, Phase I Unit. IOB - Hospital Quironsalud Barcelona, Spain
View all 13 locations
View Trial Details
Active, Not Recruiting

Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations

NCT05544552

Conditions
Advanced Solid Tumor, Advanced Urothelial Carcinoma, Bladder Cancer, +31 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • UMass Memorial Medical Center Worchester, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center (MSKCC) New York, United States
  • Duke Cancer Institute (DCI) - Duke Cancer Center Durham, North Carolina, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

NCT06714617

Conditions
Adnexal Diseases, Breast Cancer Stage III, Breast Diseases, +48 more
Locations
  • SCRI-Denver HealthOne Denver, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • SCRI-Florida Cancer Center Specialists Lake Mary Lake Mary, Florida, United States
  • Hematology Oncology Associates of the Treasure Cost Port Saint Lucie, Florida, United States
View Trial Details

Related conditions